Wolverine Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-44,667
Closed -$7.91M 1919
2020
Q1
$7.91M Buy
44,667
+4,032
+10% +$759K 0.11% 143
2019
Q4
$7.77M Buy
40,635
+8,331
+26% +$1.5M 0.09% 186
2019
Q3
$5.44M Buy
32,304
+22,861
+242% +$3.72M 0.07% 216
2019
Q2
$1.58M Buy
+9,443
New +$1.31M 0.02% 500
2019
Q1
Sell
-2,080
Closed -$278K 1832
2018
Q4
$278K Buy
+2,080
New +$341K ﹤0.01% 1174
2018
Q1
Sell
-13,615
Closed -$2.23M 1795
2017
Q4
$2.23M Buy
+13,615
New +$2.44M 0.02% 477
2017
Q1
Sell
-3,480
Closed -$810K 1482
2016
Q4
$730K Buy
+3,480
New +$721K 0.01% 601
2016
Q2
Sell
-11,388
Closed -$2.63M 1393
2016
Q1
$3.05M Buy
+11,388
New +$3.26M 0.09% 227

Other funds holding AGN

Wolverine Asset Management's AGN Position: Q2 2020 in Review

Wolverine Asset Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 44,667 shares — an estimated $7.91M sold.

Wolverine Asset Management first reported a position in AGN in Q1 2016 and held it in 8 quarters. The position peaked at $7.91M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Wolverine Asset Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Wolverine Asset Management sold 44,667 Allergan plc shares in Q2 2020, an estimated $7.91M.
  • Wolverine Asset Management first reported a position in Allergan plc in Q1 2016 and held it in 8 quarters.
  • Wolverine Asset Management's Allergan plc position peaked at $7.91M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Wolverine Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.